What does FARMA NOORD do?

FARMA NOORD is a pharmacy in Kalmthout. Private Limited, started on 6 February 2013, 1 establishment.

What is the address of FARMA NOORD?

The registered office of FARMA NOORD is located at Kapelstraat (Ab) 13, 2920 Kalmthout.

Is FARMA NOORD still active?

Yes. According to the CBE (30 October 2026) FARMA NOORD is active, legal situation “Normale toestand”, started on 6 February 2013.

Is FARMA NOORD registered on Peppol?

Yes, FARMA NOORD is registered on the Peppol network with ID 0208:0503932618.

What is the enterprise number of FARMA NOORD?

The enterprise number of FARMA NOORD is BE0503932618.

When was FARMA NOORD founded?

FARMA NOORD was founded on 6 February 2013.

Who are the directors of FARMA NOORD?

According to the 2025 annual accounts, the directors of FARMA NOORD are: Anne Arnouts.

Is FARMA NOORD a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 February 2013; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did FARMA NOORD make in 2025?

FARMA NOORD posted a profit after taxes of € 86,273 in financial year 2025.

What is the revenue of FARMA NOORD?

As a small company, FARMA NOORD is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 131,390.

FARMA NOORD (Private Limited) - Kalmthout - BE0503932618

Dossier FARMA NOORD, printed on 30 October 2026 from databakkes.be/en/0503932618/farma-noord. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

FARMA NOORD from Kalmthout, company number BE0503932618, closed financial year 2025 with a result of € 86,273 after tax. For that financial year FARMA NOORD recorded a gross margin of € 131,390 and equity of € 809,508. Compared with financial year 2024, the result moved from € 67,304 to € 86,273. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 21, 2026.

What it is worth Growing

€ 809,508

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 86,273

▲ 28% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 69,635

▲ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 797,108.

People and assets in 2025

Vehicles and equipment

€ 18,936

▲ € 18,453 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 280,824

▼ 16% vs 2024

€ 53,791 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 2,217

▲ € 2,187 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 23,692

▲ 145% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 112,567 Gross margin 2022: € 112,567 First fiscal year in the series	€ 123,468 Gross margin 2023: € 123,468 ▲ 10% vs 2022 (€ 112,567) Favourable step	€ 101,543 Gross margin 2024: € 101,543 ▼ 18% vs 2023 (€ 123,468) Unfavourable step	€ 131,390 Gross margin 2025: € 131,390 ▲ 29% vs 2024 (€ 101,543) Favourable step	▲ 29%
Profit after taxes	€ 74,442 Profit after taxes 2022: € 74,442 First fiscal year in the series	€ 82,167 Profit after taxes 2023: € 82,167 ▲ 10% vs 2022 (€ 74,442) Favourable step	€ 67,304 Profit after taxes 2024: € 67,304 ▼ 18% vs 2023 (€ 82,167) Unfavourable step	€ 86,273 Profit after taxes 2025: € 86,273 ▲ 28% vs 2024 (€ 67,304) Favourable step	▲ 28%
Equity	€ 573,764 Equity 2022: € 573,764 First fiscal year in the series	€ 655,931 Equity 2023: € 655,931 ▲ 14% vs 2022 (€ 573,764) Favourable step	€ 723,235 Equity 2024: € 723,235 ▲ 10% vs 2023 (€ 655,931) Favourable step	€ 809,508 Equity 2025: € 809,508 ▲ 12% vs 2024 (€ 723,235) Favourable step	▲ 12%
Total debts	€ 515,196 Total debts 2022: € 515,196 First fiscal year in the series	€ 405,950 Total debts 2023: € 405,950 ▼ 21% vs 2022 (€ 515,196) Favourable step	€ 347,091 Total debts 2024: € 347,091 ▼ 14% vs 2023 (€ 405,950) Favourable step	€ 310,682 Total debts 2025: € 310,682 ▼ 10% vs 2024 (€ 347,091) Favourable step	▼ 10%
Cash	€ 72,416 Cash 2022: € 72,416 First fiscal year in the series	€ 11,223 Cash 2023: € 11,223 ▼ 85% vs 2022 (€ 72,416) Unfavourable step	€ 52,340 Cash 2024: € 52,340 ▲ € 41,117 vs 2023 (€ 11,223) Favourable step	€ 69,635 Cash 2025: € 69,635 ▲ 33% vs 2024 (€ 52,340) Favourable step	▲ 33%
Retained profit	€ 561,364 Retained profit 2022: € 561,364 First fiscal year in the series	€ 643,531 Retained profit 2023: € 643,531 ▲ 15% vs 2022 (€ 561,364) Favourable step	€ 710,835 Retained profit 2024: € 710,835 ▲ 10% vs 2023 (€ 643,531) Favourable step	€ 797,108 Retained profit 2025: € 797,108 ▲ 12% vs 2024 (€ 710,835) Favourable step	▲ 12%
Dividend	€ 63,636 Dividend 2022: € 63,636 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 63,636) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 435,471 Bank debt 2022: € 435,471 First fiscal year in the series	€ 385,019 Bank debt 2023: € 385,019 ▼ 12% vs 2022 (€ 435,471) Favourable step	€ 333,478 Bank debt 2024: € 333,478 ▼ 13% vs 2023 (€ 385,019) Favourable step	€ 280,824 Bank debt 2025: € 280,824 ▼ 16% vs 2024 (€ 333,478) Favourable step	▼ 16%
Balance sheet total	€ 1,088,960 Balance sheet total 2022: € 1,088,960 First fiscal year in the series	€ 1,061,881 Balance sheet total 2023: € 1,061,881 ▼ 2% vs 2022 (€ 1,088,960) Unchanged	€ 1,070,326 Balance sheet total 2024: € 1,070,326 ▲ 1% vs 2023 (€ 1,061,881) Unchanged	€ 1,120,191 Balance sheet total 2025: € 1,120,191 ▲ 5% vs 2024 (€ 1,070,326) Unchanged	▲ 5%

Key figures of FARMA NOORD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to FARMA NOORD?

What happened at FARMA NOORD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 21, 2026 New annual accounts for financial year 2025: profit of € 86,273 (▲ 28% vs 2024). Source: NBB ↗
Feb 6, 2013 New establishment in Kalmthout. KBO
Feb 6, 2013 Start of the company according to the CBE. KBO

In short

From € 74,442 profit in 2022 to € 86,273 profit in 2025.

Paid € 118,563 in corporate taxes since 2022.

Best year ever: 2025, with € 86,273 profit.

Paid out € 63,636 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Anne Arnouts

FARMA NOORD

Apotheek Curavit 100%

Behind FARMA NOORD is Anne Arnouts. It owns 100% of Apotheek Curavit itself.

Directors

According to the 2025 annual accounts

Anne Arnouts

Director

Also active at: APOTHEEK CURAVIT

Establishments

Establishment units

Physical locations of this company

Registered office

Kapelstraat (Ab) 13

2920 Kalmthout

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0503.932.618
VAT number: BE 0503.932.618
Registered office: Kapelstraat (Ab) 13, 2920 Kalmthout
Names & denominations: FARMA NOORD
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 February 2013
Peppol: Active · Active since 14 Aug 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗